Projects per year
Personal profile
Biography
Associate Professor Miles Sparrow is a gastroenterologist specialising in inflammatory bowel disease (IBD) who is the Director of the IBD Unit at The Alfred Hospital, Melbourne and Adjunct Clinical Associate Professor at Monash University.
His research interests include use and optimisation of immunomodulators, therapeutic drug monitoring, novel E-Health models of care in IBD and clinical trials of novel experimental agents in IBD. He is a member of the Australian-IBD Association, IBD-Melbourne and BRIDGe IBD special interest groups, and is a faculty member of the Cornerstones IBD medical education program.
Research interests
Inflammatory bowel disease clinical trials of experimental new agents
Therapeutic drug monitoring in inflammatory bowel disease of thiopurine immunomodulators and biologic agents
Novel models of care including E-Health in inflammatory bowel disease
Supervision interests
Inflamatory bowel disease clinical research.
Currently qualified to supervise BMedSci medical students and to co-supervise graduate research students. Currently applying for AQF Level 10 qualification to enable primary supervision of gradulat research students.
Clinical activities
Director, Alfred Hospital Inflammatory Bowel Disease Unit and Inflammatory Bowel Disease Clinical Trials program.
Works in private practice at Brighton Gastroenterology Associates.
Education/Academic qualification
Medicine, MBBS, University of Melbourne
… → 1995
Research area keywords
- inflammatory bowel disease
Network
Projects
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Ulcerative Colitis.
Sparrow, M. & McKenzie, J.
6/10/20 → 31/12/23
Project: Research
-
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Sparrow, M. & McKenzie, J.
21/05/20 → 31/12/23
Project: Research
Research output
-
A pragmatic stepwise approach to the diagnosis and management of refractory acute pouchitis
Ardalan, Z. S. & Sparrow, M. P., Feb 2021, (Accepted/In press) In : Expert Opinion on Pharmacotherapy. 3 p.Research output: Contribution to journal › Editorial › Other › peer-review
Open Access -
Editorial: anti-drug antibodies and the benefit of assay validation
Little, R. & Sparrow, M. P., Jan 2021, In : Alimentary Pharmacology and Therapeutics. 53, 1, p. 194-195 2 p.Research output: Contribution to journal › Editorial › Other › peer-review
-
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes
Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., Bibby, B. M., Connell, W. R., Brown, S. J., Kamm, M. A., Lawrance, I. C., Vestergaard, T., Svenningsen, L., Baekdal, M., Kammerlander, H., Walsh, A., Boysen, T., Bampton, P., Radford-Smith, G., Kjeldsen, J. & 10 others, , 1 Jan 2020, In : Inflammatory Bowel Diseases. 26, 1, p. 93-102 10 p.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus) -
A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn’s disease
Srinivasan, A., van Langenberg, D. R., Little, R. D., Sparrow, M. P., De Cruz, P. & Ward, M. G., Jun 2020, In : Alimentary Pharmacology & Therapeutics. 51, 12, p. 1342-1352 11 p.Research output: Contribution to journal › Article › Research › peer-review
-
Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease
Gibson, D. J., Ward, M. G., Rentsch, C., Friedman, A. B., Taylor, K. M., Sparrow, M. P. & Gibson, P. R., Mar 2020, In : Alimentary Pharmacology & Therapeutics. 51, 6, p. 612-628 17 p.Research output: Contribution to journal › Review Article › Research › peer-review
3 Citations (Scopus)